HMGB1 and breast carcinoma: A recent study also shows that high mobility group box 1 (HMGB1) secreted from human breast cancer cells induces differentiation of monocytes into M-MDSCs and their survival (46, 47), suggesting that these cytokines will be potential therapeutic targets to prevent MAMPC accumulation and further improve immunotherapy effects metastatic breast cancer.